Rainbow Childrens Medicare Limited (RAINBOW) AI Stock Analysis

• Market Cap: ₹120.61B
• Dividend Yield: 0.22%
• Average Volume (3M): 8.91K
• Price to Earnings (P/E): 46.8
• Beta (1Y): 0.38
• Revenue Growth: 9.91%
• EPS Growth: 9.57%
• Country: IN
• Employees: 3,940
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 7.10
• Shares Outstanding: 101,559,160
• 10 Day Avg. Volume: 4,219
• 30 Day Avg. Volume: 8,914
• PEG Ratio: 4.75
• Price to Book (P/B): 9.54
• Price to Sales (P/S): 9.24
• P/FCF Ratio: 56.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 27.68
• Revenue Forecast (FY): ₹16.88B

• Rating: 66 Neutral
• Price Target: ₹1,283.00 ▼(-4.88% Downside)
• Action: Reiterated Date: 10/22/25
• Date: Action: Reiterated 10/22/25

Rainbow Childrens Medicare Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and solid cash flow generation. However, the technical analysis indicates a bearish trend, and the high P/E ratio suggests potential overvaluation, which negatively impacts the overall score.

Positive Factors

Sustained Revenue Growth

Multi-year revenue expansion demonstrates durable demand for Rainbow's services and improved scale economics. Higher revenue supports investment in capacity, specialist talent and technologies, allowing continued margin improvement and funding of network expansion without relying solely on external capital.

Strong Operational Cash Flow

Consistent operating cash generation and rising free cash flow provide financial flexibility to fund capex, repay debt, and invest in specialty services. Reliable cash conversion reduces refinancing risk and allows strategic reinvestment into high‑return pediatric and maternity capabilities.

Specialized Pediatric & Maternal Focus

A focused network in pediatrics and maternal care creates durable competitive advantages: specialist expertise, referral flows, and higher-acuity services that command premium pricing. This specialization supports differentiation, stickier patient relationships and long-term demand resilience.

Negative Factors

Rising Total Liabilities

An upward trend in liabilities can erode balance sheet flexibility over time, increasing interest and refinancing risks. If liabilities grow faster than cash flow, the company may face constraints on expansion, higher financing costs, or the need to slow capex or equity returns to preserve liquidity.

Industry Pressures on Margins

Healthcare reimbursement dynamics, rising input costs and competitive pricing can compress margins over the medium term. Sustained margin improvement depends on cost discipline, payor negotiations and utilization; failure to navigate these structural pressures could slow profit conversion of revenue growth.

Payor & Occupancy Sensitivity

Revenue and cash flow are sensitive to payer mix, occupancy and case mix; prolonged softness in occupancy or shifts toward lower‑yield payors reduce average revenue per occupied bed. This structural exposure can increase working capital needs and amplify earnings volatility in downturns.

Rainbow Childrens Medicare Limited Business Overview & Revenue Model

Company Description

Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.

How the Company Makes Money

RAINBOW generates revenue primarily through its healthcare services by charging for inpatient and outpatient treatments, surgical procedures, and consultations. The company also earns income from health insurance partnerships, where it acts as a network provider, allowing insurance companies to reimburse the costs of treatments provided to insured patients. Additionally, RAINBOW may generate revenue from ancillary services such as diagnostics, pharmacy, and rehabilitation programs. Significant partnerships with health insurance providers and collaborations with pediatric specialists contribute to RAINBOW's earnings, enabling a steady flow of patients and enhancing its reputation in the healthcare sector.

Rainbow Childrens Medicare Limited Financial Statement Overview

Summary

Rainbow Childrens Medicare Limited exhibits a robust financial performance characterized by strong revenue growth, improved profitability, and solid cash flow generation. The balance sheet strength, marked by prudent leverage and improved equity utilization, supports the company's growth strategies. While the company is well-positioned, monitoring the rise in liabilities will be important for maintaining financial health.

Income Statement

Rainbow Childrens Medicare Limited has demonstrated strong growth in revenue, increasing from 9,737.58 million INR in 2022 to 15,158.66 million INR in 2025. The gross profit margin remains robust, supported by a significant increase in EBIT and EBITDA margins over the years, indicating efficient cost management and operational efficiency. The net profit margin has also improved, reflecting healthy profitability. However, maintaining this trajectory amidst industry pressures will be crucial.

Balance Sheet

The company's balance sheet is solid, with a healthy equity ratio indicating a strong reliance on equity financing. The debt-to-equity ratio is manageable, suggesting prudent financial leverage. Return on Equity (ROE) has shown improvement, reflecting effective utilization of equity capital. However, the increase in total liabilities warrants careful monitoring to ensure continued stability.

Cash Flow

Rainbow's cash flow statements indicate strong operational cash flows, with a significant improvement in free cash flow over the recent years, suggesting efficient capital expenditure and cash management. The operating cash flow to net income ratio is favorable, highlighting the company's ability to convert net income into cash. The free cash flow growth rate has shown a positive trend, enhancing financial flexibility.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	15.39B	15.16B	12.97B	11.74B	9.74B	6.50B
Gross Profit	9.71B	10.82B	9.31B	8.44B	6.44B	4.24B
EBITDA	4.89B	4.37B	3.90B	3.65B	2.73B	1.35B
Net Income	2.57B	2.43B	2.17B	2.11B	1.38B	400.18M
Balance Sheet
Total Assets	0.00	23.77B	21.70B	17.76B	14.24B	10.81B
Cash, Cash Equivalents and Short-Term Investments	6.94B	6.94B	5.02B	3.81B	2.03B	1.03B
Total Debt	0.00	7.64B	7.65B	5.70B	5.79B	5.18B
Total Liabilities	-14.75B	9.02B	9.05B	7.06B	6.89B	6.33B
Stockholders Equity	14.75B	14.68B	12.59B	10.60B	6.03B	4.46B
Cash Flow
Free Cash Flow	0.00	2.50B	-321.75M	1.86B	1.62B	666.11M
Operating Cash Flow	0.00	3.96B	3.21B	3.27B	2.24B	1.43B
Investing Cash Flow	0.00	-2.68B	-2.26B	-4.65B	-1.75B	-828.80M
Financing Cash Flow	0.00	-1.18B	-1.02B	1.43B	-440.62M	-608.73M

Rainbow Childrens Medicare Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1348.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAINBOW, the sentiment is Negative. The current price of 1348.8 is above the 20-day moving average (MA) of 1181.75, above the 50-day MA of 1234.44, and below the 200-day MA of 1380.92, indicating a neutral trend. The MACD of -4.48 indicates Negative momentum. The RSI at 45.91 is Neutral, neither overbought nor oversold. The STOCH value of 43.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:RAINBOW.

Rainbow Childrens Medicare Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RPGLIFE	76 Outperform	₹30.88B	15.24	―	0.85%	―	―
HCG	67 Neutral	₹81.18B	423.34	―	―	17.58%	-38.20%
VIMTALABS	67 Neutral	₹20.18B	26.93	―	0.16%	17.05%	56.84%
RAINBOW	66 Neutral	₹120.61B	46.81	―	0.22%	9.91%	9.57%
JUBLPHARMA	62 Neutral	₹137.99B	31.71	―	0.46%	10.09%	-19.40%
KRSNAA	62 Neutral	₹20.57B	25.53	―	0.38%	11.51%	21.56%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Rainbow Childrens Medicare Limited Corporate Events

Rainbow Children’s Medicare Expands Bengaluru Footprint with New 90-Bed Hospital in Electronic City

Rainbow Children’s Medicare Limited has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds across India. The ₹55 crore facility, funded through internal accruals, will operate as a spoke aligned with the company’s existing hub hospital in Marathahalli, strengthening its hub-and-spoke network in a fast-growing corridor with a young population and rising healthcare needs, and offering a full spectrum of pediatric and perinatal services to deepen its presence in the strategically important Bengaluru market.